<?xml version="1.0" encoding="UTF-8"?>
<Document>
<TEXT><NODE id="0" />IV Equipment<NODE id="12" /> Market<NODE id="19" /> Expected to Witness a CAGR of 5.0% During 2017-2022.

Bild vergößern
(<NODE id="90" />Presseportal<NODE id="102" /> <NODE id="103" />openBroadcast<NODE id="116" />) - Rising cases of needle stick injuries, the shift in demand towards ambulatory surgical centers and fusion pumps, and a greater number of surgical procedures performed are poised to benefit the <NODE id="313" />IV equipment<NODE id="325" /> market<NODE id="332" />. Further more, a prevalence of chronic diseases in an ageing population in developed nations are positive signs for the <NODE id="453" />IV equipment<NODE id="465" /> market<NODE id="472" />. However, lack of wireless connectivity, regulatory mandates for new product launches and increasing cases of medication errors inhibit the unencumbered growth of the<NODE id="639" /> <NODE id="640" />IV equipment<NODE id="652" /> market <NODE id="660" />that is anticipated to witness a steady CAGR of 5% from 2017 to 2022.
Request to Download and View Full TOC @ https://www.persistencemarketresearch.com/market-research/iv-equipment-market/toc
The <NODE id="856" />IV catheter<NODE id="867" /> segment is the most popular in the <NODE id="903" />IV equipment<NODE id="915" /> market<NODE id="922" /> and should remain so for the foreseeable future. The <NODE id="976" />IV catheter<NODE id="987" /> segment is expected to be worth more than US$ 2.7 billion in 2017 itself and companies are recommended to target this segment with gusto. The <NODE id="1130" />infusion pump<NODE id="1143" /> segment is a close second in the <NODE id="1177" />IV equipment<NODE id="1189" /> market <NODE id="1197" />in terms of product type segment and is likely to be the biggest winner in terms of <NODE id="1281" />market<NODE id="1287" /> share. Key stakeholders in the<NODE id="1318" /> <NODE id="1319" />IV equipment <NODE id="1332" />market<NODE id="1338" /> would do well to focus their energy on the Europe infusion pumps market as the region accounts for more than a third of the revenue contribution
The securement device segment and <NODE id="1518" />stopclocks<NODE id="1528" /> &amp; <NODE id="1531" />valve<NODE id="1536" /> segment have single digit revenue share in the<NODE id="1583" /> <NODE id="1584" />IV equipment<NODE id="1596" /> market<NODE id="1603" />. While the former is projected to lose market share, the latter is on track to gain share and companies may seek to take advantage of this. The <NODE id="1748" />stopcock<NODE id="1756" /> &amp; <NODE id="1759" />valves<NODE id="1765" /> segment is estimated to grow with a CAGR of just under 6% from 2017 to 2022. Along with Europe, the <NODE id="1866" />stopcocks<NODE id="1875" /> &amp; <NODE id="1878" />valves<NODE id="1884" /> segment has strong potential in APEJ
Request to View Sample Report @ https://www.persistencemarketresearch.com/samples/19297
The drip chamber and <NODE id="2031" />needleless connector<NODE id="2051" /> segment have a revenue share of less than a tenth in the<NODE id="2108" /> IV equipment<NODE id="2121" /> market <NODE id="2129" />at the end of 2017. The <NODE id="2153" />needleless connector<NODE id="2173" /> segment is predicted to lose substantial share in the near future while the drip chamber segment should fall slowly. The Europe <NODE id="2302" />drip chamber<NODE id="2314" /> segment is assessed to grow past more than US$ 285 million at the end of the forecast period. The <NODE id="2413" />needleless connector<NODE id="2433" /> segment also has the greatest potential in Europe. Along with Europe, companies could additionally target the North America <NODE id="2558" />needleless connector<NODE id="2578" /> segment
Hospitals hold the lion’s share in the<NODE id="2625" /> <NODE id="2626" />IV equipment<NODE id="2638" /> market<NODE id="2645" /> by end user segment and are forecast to hold steady for the medium to long term. Hospitals are the most-well equipped to deal with any and every patient need pertaining to IV treatment. Europe is the largest region in the hospital segment of the <NODE id="2892" />IV equipment<NODE id="2904" /> market <NODE id="2912" />but there is a close competition for the second place between APEJ and North America
The companies profiled in the <NODE id="3027" />IV equipment<NODE id="3039" /> market<NODE id="3046" /> are <NODE id="3051" />AngioDynamics<NODE id="3064" />, <NODE id="3066" />Moog Inc.<NODE id="3075" />, <NODE id="3077" />Terumo Corporation<NODE id="3095" />,<NODE id="3096" /> C. R. Bard<NODE id="3107" />, <NODE id="3109" />ICU Medical<NODE id="3120" />, <NODE id="3122" />Smiths Group<NODE id="3134" />, <NODE id="3136" />Baxter International Inc.<NODE id="3161" />, <NODE id="3163" />Fresenius SE &amp; Co.<NODE id="3181" />, <NODE id="3183" />B. Braun Melsungen AG<NODE id="3204" />, and <NODE id="3210" />Becton, Dickinson and Company<NODE id="3239" />
Buy Full<NODE id="3248" /> <NODE id="3249" />IV Equipment<NODE id="3261" /> Market<NODE id="3268" /> Report @  https://www.persistencemarketresearch.com/checkout/19297
 
Firmenportrait:
<NODE id="3354" />Future Market Insights<NODE id="3376" /> (<NODE id="3378" />FMI<NODE id="3381" />) is a leading market intelligence and consulting <NODE id="3431" />firm<NODE id="3435" />. <NODE id="3437" />We<NODE id="3439" /> deliver syndicated<NODE id="3458" /> research reports<NODE id="3475" />, <NODE id="3477" />custom research reports<NODE id="3500" /> and <NODE id="3505" />consulting services<NODE id="3524" />, which are personalized in nature.
Bitte beachten Sie, dass für den Inhalt der hier veröffentlichten Meldung nicht openBroadcast verantwortlich ist, sondern der Verfasser der jeweiligen Meldung selbst. AGB | Haftungsausschluss .

</TEXT>
<Meta>
<feature featureName="Category" featureValue="" />
<feature featureName="Publication" featureValue="" />
<feature featureName="id" featureValue="http://www.openbroadcast.de/article/506157/iv-equipment-market-expected-to-witness-a-cagr-of-5.0-during-2017-2022.html@2017-10-20T12:29:41.000+02:00" />
<feature featureName="uri" featureValue="http://www.openbroadcast.de/article/506157/iv-equipment-market-expected-to-witness-a-cagr-of-5.0-during-2017-2022.html" />
<feature featureName="lang" featureValue="en" /></Meta><Entities>
<Entity id="0" startPos="0" endPos="12" type="product" surface="IV Equipment" />
<Entity id="1" startPos="0" endPos="19" type="industry" surface="IV Equipment Market" />
<Entity id="2" startPos="90" endPos="102" type="product" surface="Presseportal" />
<Entity id="3" startPos="103" endPos="116" type="product" surface="openBroadcast" />
<Entity id="4" startPos="313" endPos="325" type="product" surface="IV equipment" />
<Entity id="5" startPos="313" endPos="332" type="industry" surface="IV equipment market" />
<Entity id="6" startPos="453" endPos="465" type="product" surface="IV equipment" />
<Entity id="7" startPos="453" endPos="472" type="industry" surface="IV equipment market" />
<Entity id="8" startPos="639" endPos="652" type="product" surface=" IV equipment" />
<Entity id="9" startPos="640" endPos="660" type="industry" surface="IV equipment market " />
<Entity id="10" startPos="856" endPos="867" type="product" surface="IV catheter" />
<Entity id="11" startPos="903" endPos="915" type="product" surface="IV equipment" />
<Entity id="12" startPos="903" endPos="922" type="industry" surface="IV equipment market" />
<Entity id="13" startPos="976" endPos="987" type="product" surface="IV catheter" />
<Entity id="14" startPos="1130" endPos="1143" type="product" surface="infusion pump" />
<Entity id="15" startPos="1177" endPos="1189" type="product" surface="IV equipment" />
<Entity id="16" startPos="1177" endPos="1197" type="industry" surface="IV equipment market " />
<Entity id="17" startPos="1281" endPos="1287" type="industry" surface="market" />
<Entity id="18" startPos="1318" endPos="1332" type="product" surface=" IV equipment " />
<Entity id="19" startPos="1319" endPos="1338" type="industry" surface="IV equipment market" />
<Entity id="20" startPos="1518" endPos="1528" type="product" surface="stopclocks" />
<Entity id="21" startPos="1531" endPos="1536" type="product" surface="valve" />
<Entity id="22" startPos="1583" endPos="1596" type="product" surface=" IV equipment" />
<Entity id="23" startPos="1584" endPos="1603" type="industry" surface="IV equipment market" />
<Entity id="24" startPos="1748" endPos="1756" type="product" surface="stopcock" />
<Entity id="25" startPos="1759" endPos="1765" type="product" surface="valves" />
<Entity id="26" startPos="1866" endPos="1875" type="product" surface="stopcocks" />
<Entity id="27" startPos="1878" endPos="1884" type="product" surface="valves" />
<Entity id="28" startPos="2031" endPos="2051" type="product" surface="needleless connector" />
<Entity id="29" startPos="2108" endPos="2121" type="product" surface=" IV equipment" />
<Entity id="30" startPos="2108" endPos="2129" type="industry" surface=" IV equipment market " />
<Entity id="31" startPos="2153" endPos="2173" type="product" surface="needleless connector" />
<Entity id="32" startPos="2302" endPos="2314" type="product" surface="drip chamber" />
<Entity id="33" startPos="2413" endPos="2433" type="product" surface="needleless connector" />
<Entity id="34" startPos="2558" endPos="2578" type="product" surface="needleless connector" />
<Entity id="35" startPos="2625" endPos="2645" type="industry" surface=" IV equipment market" />
<Entity id="36" startPos="2626" endPos="2638" type="product" surface="IV equipment" />
<Entity id="37" startPos="2892" endPos="2904" type="product" surface="IV equipment" />
<Entity id="38" startPos="2892" endPos="2912" type="industry" surface="IV equipment market " />
<Entity id="39" startPos="3027" endPos="3039" type="product" surface="IV equipment" />
<Entity id="40" startPos="3027" endPos="3046" type="industry" surface="IV equipment market" />
<Entity id="41" startPos="3051" endPos="3064" type="organization" surface="AngioDynamics" />
<Entity id="42" startPos="3066" endPos="3075" type="organization" surface="Moog Inc." />
<Entity id="43" startPos="3077" endPos="3095" type="organization" surface="Terumo Corporation" />
<Entity id="44" startPos="3096" endPos="3107" type="organization" surface=" C. R. Bard" />
<Entity id="45" startPos="3109" endPos="3120" type="organization" surface="ICU Medical" />
<Entity id="46" startPos="3122" endPos="3134" type="organization" surface="Smiths Group" />
<Entity id="47" startPos="3136" endPos="3161" type="organization" surface="Baxter International Inc." />
<Entity id="48" startPos="3163" endPos="3181" type="organization" surface="Fresenius SE &amp; Co." />
<Entity id="49" startPos="3183" endPos="3204" type="organization" surface="B. Braun Melsungen AG" />
<Entity id="50" startPos="3210" endPos="3239" type="organization" surface="Becton, Dickinson and Company" />
<Entity id="51" startPos="3248" endPos="3268" type="industry" surface=" IV Equipment Market" />
<Entity id="52" startPos="3249" endPos="3261" type="product" surface="IV Equipment" />
<Entity id="53" startPos="3354" endPos="3376" type="organization" surface="Future Market Insights" />
<Entity id="54" startPos="3378" endPos="3381" type="organization" surface="FMI" />
<Entity id="55" startPos="3431" endPos="3435" type="organization" surface="firm" />
<Entity id="56" startPos="3437" endPos="3439" type="organization" surface="We" />
<Entity id="57" startPos="3458" endPos="3475" type="product" surface=" research reports" />
<Entity id="58" startPos="3477" endPos="3500" type="product" surface="custom research reports" />
<Entity id="59" startPos="3505" endPos="3524" type="product" surface="consulting services" /></Entities><Relations>
<Relation id="60" NAME="identity">
<Entity id="0" label="source" />
<Entity id="4" label="target" />
<Entity id="22" label="target" />
<Entity id="36" label="target" />
<Entity id="18" label="target" />
<Entity id="29" label="target" />
<Entity id="52" label="target" />
<Entity id="39" label="target" />
<Entity id="37" label="target" />
<Entity id="15" label="target" />
<Entity id="6" label="target" />
<Entity id="11" label="target" />
<Entity id="8" label="target" />
</Relation>
<Relation id="61" NAME="identity">
<Entity id="1" label="source" />
<Entity id="30" label="target" />
<Entity id="23" label="target" />
<Entity id="51" label="target" />
<Entity id="19" label="target" />
<Entity id="9" label="target" />
<Entity id="35" label="target" />
<Entity id="5" label="target" />
<Entity id="7" label="target" />
<Entity id="38" label="target" />
<Entity id="17" label="target" />
<Entity id="12" label="target" />
<Entity id="40" label="target" />
<Entity id="16" label="target" />
</Relation>
<Relation id="62" NAME="identity">
<Entity id="2" label="source" />
<Entity id="3" label="target" />
</Relation>
<Relation id="63" NAME="identity">
<Entity id="10" label="source" />
<Entity id="13" label="target" />
</Relation>
<Relation id="64" NAME="identity">
<Entity id="20" label="source" />
<Entity id="24" label="target" />
<Entity id="26" label="target" />
</Relation>
<Relation id="65" NAME="identity">
<Entity id="21" label="source" />
<Entity id="27" label="target" />
<Entity id="25" label="target" />
</Relation>
<Relation id="66" NAME="identity">
<Entity id="28" label="source" />
<Entity id="34" label="target" />
<Entity id="33" label="target" />
<Entity id="31" label="target" />
</Relation>
<Relation id="67" NAME="identity">
<Entity id="53" label="source" />
<Entity id="56" label="target" />
<Entity id="55" label="target" />
<Entity id="54" label="target" />
</Relation></Relations>
</Document>
